Financials LifeTech Scientific Corporation

Equities

Market Closed - Hong Kong S.E. Other stock markets 04:08:22 2024-04-29 am EDT			5-day change	1st Jan Change
1.69 ^HKD	+0.60%		+5.62%	-28.09%

Apr. 11	Lifetech Scientific Buys Shares For Employee Incentive Scheme	MT
Apr. 04	Lifetech Scientific Unit Invests 340 Million Yuan in Structured Deposits	MT

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025
Capitalization ¹	5,752	17,330	13,808	10,550	9,890	7,244	-
Enterprise Value (EV) ¹	5,734	16,373	13,808	10,550	9,890	7,244	7,244
P/E ratio	43 x	76.4 x	46.6 x	30.8 x	36.2 x	22.2 x	17.3 x
Yield	-	-	-	-	-	-	-
Capitalization / Revenue	8.6 x	27 x	14.9 x	-	7.8 x	4.91 x	4.08 x
EV / Revenue	8.6 x	27 x	14.9 x	-	7.8 x	4.91 x	4.08 x
EV / EBITDA	38.3 x	53 x	-	-	-	15.5 x	13.2 x
EV / FCF	302,807,058 x	79,697,552 x	64,815,519 x	-	-	-	-
FCF Yield	0%	0%	0%	-	-	-	-
Price to Book	4.99 x	7.4 x	5.14 x	-	-	2.07 x	1.85 x
Nbr of stocks (in thousands)	4,320,033	4,626,998	4,630,030	4,630,030	4,630,232	4,630,512	-
Reference price ²	1.332	3.745	2.982	2.279	2.136	1.555	1.555
Announcement Date	3/30/20	3/30/21	3/30/22	3/29/23	3/28/24	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025
Net sales ¹	668.9	642.3	925.3	-	1,267	1,474	1,774
EBITDA ¹	150	327.1	-	-	-	467	550
EBIT ¹	94.84	264.5	328.7	-	383.3	379	456
Operating Margin	14.18%	41.18%	35.53%	-	30.25%	25.71%	25.7%
Earnings before Tax (EBT) ¹	170.8	242.6	332.9	-	175.6	379	460
Net income ¹	129.2	216.1	292.5	325.3	263.2	328	399
Net margin	19.32%	33.64%	31.61%	-	20.77%	22.25%	22.49%
EPS ²	0.0310	0.0490	0.0640	0.0740	0.0590	0.0700	0.0900
Free Cash Flow	19	217.4	213	-	-	-	-
FCF margin	2.84%	33.85%	23.02%	-	-	-	-
FCF Conversion (EBITDA)	12.66%	66.47%	-	-	-	-	-
FCF Conversion (Net income)	14.7%	100.63%	72.84%	-	-	-	-
Dividend per Share	-	-	-	-	-	-	-
Announcement Date	3/30/20	3/30/21	3/30/22	3/29/23	3/28/24	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025
Net Debt	-	-	-	-	-	-	-
Net Cash position	18.8	957	-	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-
Free Cash Flow	19	217	213	-	-	-	-
ROE (net income / shareholders' equity)	10.8%	12.4%	12.1%	-	-	9.9%	10.8%
ROA (Net income/ Total Assets)	7.82%	9.14%	-	-	-	7.9%	8.8%
Assets ¹	1,652	2,363	-	-	-	4,152	4,534
Book Value Per Share ²	0.2700	0.5100	0.5800	-	-	0.7500	0.8400
Cash Flow per Share ²	-	-	-	-	-	0.0700	0.0900
Capex ¹	114	105	276	-	-	153	103
Capex / Sales	17.05%	16.36%	29.81%	-	-	10.38%	5.81%
Announcement Date	3/30/20	3/30/21	3/30/22	3/29/23	3/28/24	-	-

¹CNY in Million²CNY

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.555 CNY

Average target price

2.436 CNY

Spread / Average Target

+56.64%

	1st Jan change	Capi.
LIFETECH SCIENTIFIC CORPORATION	-28.09%	994M
THERMO FISHER SCIENTIFIC	+9.10%	219B
DANAHER CORPORATION	+7.56%	183B
INTUITIVE SURGICAL, INC.	+11.25%	133B
BOSTON SCIENTIFIC CORPORATION	+25.35%	108B
SIEMENS HEALTHINEERS AG	+0.27%	63.06B
EDWARDS LIFESCIENCES CORPORATION	+12.87%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	+0.36%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+13.24%	39.35B